Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000216508 | SCV000270567 | likely benign | not specified | 2015-03-13 | criteria provided, single submitter | clinical testing | p.Asp1180Gly in exon 23 of MYOM1: This variant is not expected to have clinical significance because it has been identified in 0.5% (51/9800) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs188319622). |
Labcorp Genetics |
RCV000458238 | SCV000561226 | benign | Hypertrophic cardiomyopathy | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000216508 | SCV003857540 | uncertain significance | not specified | 2022-12-23 | criteria provided, single submitter | clinical testing | The p.D1180G variant (also known as c.3539A>G), located in coding exon 22 of the MYOM1 gene, results from an A to G substitution at nucleotide position 3539. The aspartic acid at codon 1180 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Center for Genomics, |
RCV003227718 | SCV003924127 | uncertain significance | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | MYOM1 NM_003803.3 exon 23 p.Asp1180Gly (c.3539A>G): This variant has not been reported in the literature and is present in 0.5% (137/24170) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/18-3102508-T-C). This variant is present in ClinVar (Variation ID:227701). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Breakthrough Genomics, |
RCV003227718 | SCV005214871 | likely benign | not provided | criteria provided, single submitter | not provided |